Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
| Description | Erythromycin ethyl succinate 250mg/5ml oral suspension (Sigma Pharmaceuticals Plc) |
| BNF code | 0501050H0AAABAB |
| Virtual Medicinal Product | Erythromycin ethyl succinate 250mg/5ml oral suspension |
| Name | Erythromycin ethyl succinate 250mg/5ml oral suspension |
| Supplier | Sigma Pharmaceuticals Plc |
| Current licensing authority | Medicines - MHRA/EMA |
| EMA additional monitoring | ✗ |
| Parallel import | ✗ |
| Restrictions on availability | None |
| Licensed Route | |
|---|---|
| Licenced route | Oral |
| Actual Medicinal Product Packs | |
| Erythromycin ethyl succinate 250mg/5ml oral suspension (Sigma Pharmaceuticals Plc) 100 ml | |
dm+d data retrieved from TRUD: release NHSBSA_11.3.0_20241125000001, imported on 26th November 2024 at 03:54:16.